Tag results:

cardiomyocytes

CU06-1004 Enhances Vascular Integrity and Improves Cardiac Remodeling by Suppressing Edema and Inflammation in Myocardial Ischemia–Reperfusion Injury

[Experimental and Molecular Medicine] Investigators found that CU06-1004, as a vascular leakage blocker, could improve cardiac function by inhibiting cardiac microvascular endothelial cells' hyperpermeability and subsequently reducing the neutrophil’s plugging and infiltration in infarcted hearts.

A Versatile and Robust Cell Purification System with an RNA-Only Circuit Composed of microRNA-Responsive ON and OFF Switches

[Science Advances] By designing RNA-only circuits with miRNA-ON and -OFF switch mRNAs that encoded a lethal ribonuclease, Barnase, and its inhibitor, Barstar, the authors efficiently purified specific cell types, including human iPSCs and differentiated cardiomyocytes, without flow cytometry.

Transforming Growth Factor-β in Myocardial Disease

[Nature Review Cardiology] The author summarizes the current evidence on the role of TGFβ signaling in myocardial diseases, focusing on cellular targets and molecular mechanisms, and discussing challenges and opportunities for therapeutic translation.

Aligned Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Improves Contractile Properties through Promoting Unidirectional and Synchronous Cardiomyocyte Contraction

[Biomaterials] Scientists fabricated aligned human cardiac tissue using a micro-processed fibrin gel with inverted V-shaped ridges and elucidated the effect of alignment control on contractile properties.

Transforming Growth Factor-β in Myocardial Disease

[Nature Reviews Cardiology] The authors summarize the current evidence on the role of TGFβ signaling in myocardial diseases, focusing on cellular targets and molecular mechanisms, and discuss challenges and opportunities for therapeutic translation.

Interaction of SARS-CoV-2 with Cardiomyocytes: Insight into the Underlying Molecular Mechanisms of Cardiac Injury and Pharmacotherapy

[Biomedicine & Pharmacotherapy] The authors provide an overview of the pathways involved with cardiomyocyte in COVID-19 subjects to help promoting pharmacotherapies that can protect against SARS-CoV-2-induced cardiac injuries.

Popular